{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T19:28:47Z","timestamp":1772220527575,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006751","name":"Center for Biomedical Research in Mental Health Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Government of Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Government of Andalusia Ministry of Economy Science Innovation and Employment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Government of Spain Ministry of Health Consumer Affairs and Social Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Government of Andalusia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.euroneuro.2021.04.016","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T06:35:47Z","timestamp":1621492547000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sustained escitalopram administration affects glucose metabolism in the rat brain"],"prefix":"10.1016","volume":"51","author":[{"given":"L.","family":"Perez-Caballero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Soto-Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Desco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Mico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Berrocoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2021.04.016_bib0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cmpb.2011.06.008","article-title":"Software architecture for multi-bed FDK-based reconstruction in X-ray CT scanners","volume":"107","author":"Abella","year":"2012","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-015-1576-3","article-title":"Antidepressant Effects of Ketamine Are Not Related to (1)(8)F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats","volume":"40","author":"Baptista","year":"2015","journal-title":"Neurochem Res"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168689","article-title":"Response to Deep Brain Stimulation in Three Brain Targets with Implications in Mental Disorders: a PET Study in Rats","volume":"11","author":"Casquero-Veiga","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjp.0705800","article-title":"Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors","volume":"142","author":"Ceglia","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1139\/jpn.0930","article-title":"Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area","volume":"34","author":"Dremencov","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0006","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0007","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2016.05.044","article-title":"Blood oxygen level-dependent signals via fMRI in the mood-regulating circuit using two animal models of depression are reversed by chronic escitalopram treatment","volume":"311","author":"Hui","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2008.12.024","article-title":"Effects of fluoxetine on the rat brain in the forced swimming test: a [F-18]FDG micro-PET imaging study","volume":"451","author":"Jang","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0009","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.yic.0000194375.42589.c3","article-title":"Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis","volume":"21","author":"Kasper","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuroimage.2011.07.082","article-title":"Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI","volume":"59","author":"Klomp","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0011","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00213-006-0344-0","article-title":"Mapping the central effects of ketamine in the rat using pharmacological MRI","volume":"186","author":"Littlewood","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S1461145705006462","article-title":"Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies","volume":"10","author":"Mansari","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0013","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0006-3223(00)01036-2","article-title":"Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response","volume":"48","author":"Mayberg","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0014","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00429-014-0924-4","article-title":"Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5-B9) to the forebrain and brainstem","volume":"221","author":"Muzerelle","year":"2016","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(01)03338-8","article-title":"Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors","volume":"926","author":"Nakao","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11307-008-0166-z","article-title":"Automated method for small-animal PET image registration with intrinsic validation","volume":"11","author":"Pascau","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(25)22843-9","article-title":"Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo","volume":"271","author":"Prisco","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41398-018-0310-8","article-title":"Enhanced fear memories and brain glucose metabolism ((18)F-FDG-PET) following sub-anesthetic intravenous ketamine infusion in Sprague-Dawley rats","volume":"8","author":"Radford","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0019","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-002-1364-z","article-title":"Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities","volume":"167","author":"Sanchez","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0020","series-title":"17th Meeting of the Int'l Soc Mag Res in Med, Hawaii, USA","first-page":"1086","article-title":"SPMMouse: a new toolbox for SPM in the animal brain","author":"Sawiak","year":"2009"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0021","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-010-2084-4","article-title":"Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging","volume":"213","author":"Sekar","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0022","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroimage.2004.01.015","article-title":"Limbic-frontal circuitry in major depression: a path modeling metanalysis","volume":"22","author":"Seminowicz","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nicl.2014.08.008","article-title":"Statistical normalization techniques for magnetic resonance imaging","volume":"6","author":"Shinohara","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.016_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S1461145710000489","article-title":"Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum","volume":"14","author":"West","year":"2011","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:59:40Z","timestamp":1760378380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":25,"alternative-id":["S0924977X21002133"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.016","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained escitalopram administration affects glucose metabolism in the rat brain","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}